IMMUNOGENICITY PRIMING RADIATION THERAPY

Welcome to the Brand page for “IMMUNOGENICITY PRIMING RADIATION THERAPY”, which is offered here for Cells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products comprising cells; products comprising cell-derived preparations; products comprising biologics; kits comprised of cells, other reagents and instructions; kits comprised of cell-derived preparations, other reagents and instructions for the use thereof; kits comprised of biologics, other reagents and instructions for the use thereof; all of the foregoing for clinical, medical, veterinary and therapeutic use in combination with radiation therapy in the treatment and/or prevention of cancer and infectious diseases;medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of cells and cell-derived preparations; medical treatment of cancer and infectious diseases using radiation therapy in combination with the administration of preparations comprising biologics; providing medical information in the fields of cancer and infectious diseases;research in the field of cancer and infectious diseases; product development in the fields of science, medicine, pharmaceuticals, veterinary medicine, therapeutics and research related thereto for use in combination with radiation therapy;.

Its status is currently believed to be active. Its class is unavailable. “IMMUNOGENICITY PRIMING RADIATION THERAPY” is believed to be currently owned by “IMMUNITYBIO, INC.”